149 Bio
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1951 NW 7th Ave Ste 600, Miami, Florida,...Phone Number
(305) 306-0015Website
www.149bio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
About 149 Bio
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is 149 Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if 149 Bio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once 149 Bio has new funding data
Check if 149 Bio has recently received funding, and reach out quickly before it becomes old news!
149 Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on 149 Bio recently announced quarterly report
Product Launch: Get notified when 149 Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at 149 Bio
Check out if 149 Bio is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined 149 Bio as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
149 Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
149 Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about 149 Bio.
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding 149 Bio
AlloSite Tx is focused on developing innovative therapeutics targeting integrin activators for kidney diseases. Their lead product, ONT01, is an oral, selective small molecule integrin CD11b agonist aimed at treating lupus nephritis. The company utilizes a proprietary AI-enabled CellStaple Platform to discover new antibody and small molecule therap... Read More
